Open original FDA record ↗Recall record
- FDA identifier
- Z-1956-2018
- Company in FDA record
- Roche Molecular Systems, Inc.
- FDA record creation date
- May 30, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Cross-contamination of samples has been reported when running the existing protocol on the system with the rack-based purification run.
Source facts
- Action
- Customers were notified of the field action by letter on 4/27/18. The letter included the following required actions: " If you used the MagNA Pure 24 Pathogen 200 and/or Pathogen 1000 protocols to extract nucleic acids for an assay for a chronic infectious disease (e.g., Hepatitis C Virus), then suspected false positives should be evaluated further following local procedures and retested as necessary. " Complete the attached fax form and fax it to 1-844-861-6232 or email it to roche6612@stericycle.com. " File this Urgent Medical Device Correction (UMDC) for future reference.
- Initiated
- 2018-05-02
- Root cause
- Software in the Use Environment
- Terminated
- 2019-04-30
- Distribution
- Worldwide Distribution - US Nationwide in the states of: CA, GA, HI, IN, MD, ME, MI, MN, NC, NY, PA, VI, and WI. The products were distributed to the following foreign countries: Austria, Belgium, Brazil, Chile, China, Columbia, Costa Rica, Czech Republic, Denmark, France, Germany, Guatemala, Hong Kong, Hungary, India, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Singapore, Slovenia, South Africa, South Korea, Spain, Switzerland, Taiwan, UAE, United Kingdom, Vietnam.
- Recall number
- Z-1956-2018
- Recall status
- Terminated
- CDRH record ID
- 163850
- FDA record created
- 2018-05-30
- Recall event number
- 79899